In our newest paper, we explored a 3-fraction regimen of stereotactic body radiotherapy (SBRT) for locally advanced pancreatic cancer. We found no dose-limiting toxicities & maintenance of patients' quality of life. Learn more: redjournal.org/article/S0360-…

Phase II trial of SINGLE fraction (25 Gy) RT to celiac plexus for pain.

Of 90 pts, 53% had pain decrease, decrease in opioid usage & improved QOL.

Celiac plexus pain often debilitating & medication refractory.

Single fx RT looks convenient & effective!

#GI23 @Oncoalert

Join multidisciplinary experts on Nov. 18-19 in #NYC for a state-of-the-art review of all aspects of #pancreascancer , including epidemiology, genomics, immunology & treatment. Patients invited complimentary. Register ➡️ bit.ly/3B45n90

#MSKpancreasCME #pancreaticcancer

Final results of CURB (Ph2 of SBRT + SOC vs SOC to breast and lung ca OMD) presented by Dr. C. Jillian Tsai, MD, PhD (previously Memorial Sloan Kettering Radiation Oncology, now Princess Margaret Cancer Centre). Persistent PFS seen in 🫁 not in breast (mostly TNBC). Breast data 🤝 BR002. Biology matters, need biomarkers #astro22 #radonc

Excellent early prospective data in support of ablative MRgRT for Pancreas ca. Well done!!! Parag Parikh Michael Chuong #ASTRO2022

Strong evidence to support SBRT for HCC! Esp for pts with MVI-improvement in OS from 9 to 28mo #NRG #ASTRO2022 thank you and congrats! Laura Dawson for RTOG 1112

Proud effort of @sloan_kettering James Harding Ghassan Abou-Alfa and team. Great clinical trial and a wake up call about #VEGF and #TGFB role in #HCC if any. Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma onlinelibrary.wiley.com/doi/full/10.10…

Another step toward personalized therapy in pancreatic cancer--Olaparib Monotherapy for the BRCAness Phenotype in Previously Treated Pancreatic Cancer ja.ma/3fDwwqm via JAMA Oncology part of JAMA Network

Death toll of the pandemic- 20% Excess Deaths in the US since 3/2020 - over 2/3 directly linked to covid19 ja.ma/3meRZHf via JAMA part of JAMA Network

ALLIANCE A021101 of periop mFOLFIRINOX in BRPC. Hard to explain the difference in resectability with the replacement of one cycle by short radiation! Also question choice of short course RT vs CRT. #GI21

Congratulations @mkatzmd Alliance for Clinical Trials in Oncology @RSnyder_MD for excellent presentation #GI21 and discussion - results of A021501 directly inform practice for BR pancreas cancer!

Spirited panel discussion re apparent lack of benefit for pre-op SBRT in improving R0 resection in borderline resectable PDAC patients at ASCO #GI21 . Thank you Parag Parikh, William A Hall, MD, Dr. Van Tienhoven, @mkatzmd! Patient selection for pre-op RT? RT technique and timing?